NanJing Pharmaceutical Co Ltd
SSE:600713
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
NanJing Pharmaceutical Co Ltd
SSE:600713
|
CN |
|
I
|
IM Co Ltd
KOSDAQ:101390
|
KR |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is NanJing Pharmaceutical Co Ltd's stock price target?
Not Available
NanJing Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is NanJing Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-8%
For the last 13 years the
compound annual growth rate for
NanJing Pharmaceutical Co Ltd's revenue is
9%.
The projected
CAGR
for the next 7 years is
-8%.
What is NanJing Pharmaceutical Co Ltd's Operating Income forecast?
Projected CAGR
-16%
The
compound annual growth rate
of NanJing Pharmaceutical Co Ltd's operating income for the next 9 years is
-16%.
What is NanJing Pharmaceutical Co Ltd's Net Income forecast?
Projected CAGR
-9%
The
compound annual growth rate
of NanJing Pharmaceutical Co Ltd's net income for the next 7 years is
-9%.
